Literature DB >> 27141011

Paediatric reference ranges for faecal calprotectin: a UK study.

Fiona Davidson1, Robert J Lock2.   

Abstract

Background Faecal calprotectin has been shown to be a useful non-invasive marker for the diagnosis and monitoring of inflammatory bowel disease in children and adults. Although there are well-established reference ranges for the diagnosis of inflammatory bowel disease in adults, these have been less well studied in children. The objective was to establish reference ranges in our local population. Method All faecal calprotectin results from 2011 to 2014 were retrospectively collated and grouped according to patient age. Probability plots were used to determine expected upper limit of normal for each age group, and Mann-Whitney test was used to determine statistical difference between groups. Results Upper limit of normal for age groups 1-3.9 years, 4-17.9 years and 18 years plus were 77, 62 and 61  µg/g, respectively. There was a significant difference ( P = 0.0013) between the median calprotectin concentration for the age group 1-3.9 years ( n = 87) and 4-17.9 years ( n = 636) and between the age group 1-3.9 years and 18 years plus ( n = 7953, P = 0.0001), but there was no significant difference between the age groups 4-17.9 years and 18 years plus ( P = 0.4206). Conclusions In our local population, faecal calprotectin varies with age. Children aged 1-3.9 years had higher concentrations of faecal calprotectin than adults, but there was no significant difference in faecal calprotectin between older children and adults. This is in agreement with other published studies; however, the faecal calprotectin upper limit of normal calculated for children aged 1-3.9 years was lower than has been observed elsewhere.

Entities:  

Keywords:  Calprotectin; inflammatory bowel disease; paediatric; reference ranges

Mesh:

Substances:

Year:  2016        PMID: 27141011     DOI: 10.1177/0004563216639335

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

1.  Utility of Diagnostic Tests in Children With Functional Abdominal Pain Disorders.

Authors:  Alejandro Llanos-Chea; Miguel Saps
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-08

2.  Faecal Inflammatory Biomarkers and Gastrointestinal Symptoms after Bariatric Surgery: A Longitudinal Study.

Authors:  Floris Westerink; Inge Huibregtse; Marieke De Hoog; Sjoerd Bruin; Eelco Meesters; Desiderius Brandjes; Victor Gerdes
Journal:  Inflamm Intest Dis       Date:  2021-04-14

3.  A Study of Fecal Calprotectin in Obese Children and Adults.

Authors:  Shin Young Park; Woo Jin Kim
Journal:  J Obes Metab Syndr       Date:  2018-12-30

4.  Fecal calprotectin in healthy children aged 4-16 years.

Authors:  María Roca; Ana Rodriguez Varela; Eva Carvajal; Ester Donat; Francisco Cano; Ana Armisen; Maria Jose Vaya; Helena Ekoff; David Hervas; Niclas Rydell; Carmen Ribes-Koninckx
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

5.  Guidance on the interpretation of faecal calprotectin levels in children.

Authors:  Martina Orfei; Marco Gasparetto; Kai O Hensel; Florian Zellweger; Robert B Heuschkel; Matthias Zilbauer
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

Review 6.  Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions.

Authors:  Rachel Y Tam; Josie M van Dorst; Isabelle McKay; Michael Coffey; Chee Y Ooi
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

7.  Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age.

Authors:  Marta Velasco Rodríguez-Belvís; Javier Francisco Viada Bris; Carmen Plata Fernández; Alberto García-Salido; Julia Asensio Antón; Gloria Domínguez Ortega; Rosa Ana Muñoz Codoceo
Journal:  Paediatr Child Health       Date:  2019-06-17       Impact factor: 2.253

8.  Faecal regenerating 1B protein concentration is not associated with child growth in rural Malawi.

Authors:  Zhifei Liu; Yue-Mei Fan; Per Ashorn; Yin Bun Cheung; Lotta Hallamaa; Heikki Hyöty; Kenneth Maleta; Kirsi-Maarit Lehto; Sami Oikarinen; Seppo Parkkila; Ulla Ashorn
Journal:  J Paediatr Child Health       Date:  2020-10-28       Impact factor: 1.954

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.